CDC Forced to Admit It Doesn’t Collect Data on Natural Immunity to COVID

In response to a Freedom of Information Act request, the Centers for Disease and Control said it has no record of an individual previously infected with COVID becoming reinfected or transmitting the virus to others — because the agency doesn’t collect that data.

By Michael Nevradakis, Ph.D.

Source: https://childrenshealthdefense.org/defender/cdc-data-natural-immunity-covid

Miss a day, miss a lot. Subscribe to The Defender’s Top News of the DayIt’s free.

The Centers for Disease Control (CDC), in response to a Freedom of Information Act (FOIA) request, said it has no record of an individual previously infected with COVID becoming reinfected and transmitting the virus to others.

The FOIA request, submitted Sept. 2 by attorney Aaron Siri of the Siri & Glimstad law firm on behalf of the Informed Consent Action Network (ICAN), sought the following information:

“Documents reflecting any documented case of an individual who: (1) never received a COVID vaccine; (2) was infected with COVID once, recovered, and then later became infected again; and (3) transmitted SARS-CoV-2 to another person when reinfected.”

The CDC responded Nov. 5, stating:

“A search of our records failed to reveal any documents pertaining to your request. The CDC Emergency Operations Center (EOC) conveyed that this information is not collected.”

According to Siri, the revelation that the CDC does not collect data on people who have acquired natural immunity to the virus raises questions about vaccine mandates, specifically how the the government, or employers can mandate vaccines for people who may not need them and who could be at a greater-than-average risk of experiencing an adverse reaction to the shots.

In a blog post, Siri wrote:

“… yet the CDC is actively crushing the rights of millions of naturally immune individuals in this country if they do not get the vaccine on the assumption they can transmit the virus. But despite clear proof the vaccinated spread the virus, the CDC lifts restrictions on the vaccinated?! That is dystopian.”

Siri added:

“Every single peer reviewed study has found that the naturally immune have far greater than 99% protection from having COVID, and this immunity does not wane. In contrast, the COVID vaccine provides, at best, 95% protection and this immunity wanes rapidly. I am no mathematician, but a constant 99% seems preferable to a 95% that quickly drops.”

The response from the CDC came as part of a broader exchange between the agency and Siri’s law firm, dating back to this past summer, in which ICAN and Siri’s law firm submitted a citizen’s petition to the CDC calling for restrictions on those individuals with natural immunity to be lifted.

What do the data show?

As far back as last year, CDC Director Rochelle Walensky, argued, “there is no evidence for lasting protective immunity to SARS-CoV-2 following natural infection.”

Yet data collected from numerous studies show just the opposite of what the CDC and public health authorities claim in their far-reaching vaccination campaign. In fact, many studies show individuals who have acquired natural immunity demonstrate a stronger and longer-lasting level of immunity and a decreased likelihood to transmit COVID to others.

The Brownstone Institute, founded in May 2021 in response to “the global crisis created by policy responses to the COVID-19 pandemic of 2020,” documented 81 peer-reviewed scientific studies which all come to the same conclusion: Natural immunity confers more effective and longer-lasting protection against COVID than vaccine-induced immunity.

The same institute previously documented 30 peer-reviewed scientific studies on natural immunity in relation to COVID infection.

Further examples abound. For instance, the Cleveland Clinic in June published a preprint study showing individuals previously infected with COVID were less likely to be reinfected than fully vaccinated individuals who never contracted the virus.

The authors of the Cleveland Clinic study concluded vaccination provides no additional benefit to those who already have acquired natural immunity.

In another recent preprint study, conducted by Israeli researchers, individuals fully vaccinated with the Pfizer-BioNTech vaccine were found to be 6 to 13 times more likely to be infected with the Delta variant as compared to those with natural immunity.

The FOIA request filed Siri’s law firm on behalf of ICAN and provided data from numerous other global studies, supported by a group of expert witnesses, including:

  • Research conducted by the National Institutes of Health examined the likelihood of reinfection in people carrying antibodies against COVID, collecting data from more than 3.2 million people who had undergone antibody testing. Researchers found those individuals with antibodies became less likely to test positive for COVID as time went on.

The authors of the study wrote: “The data from this study suggest that people who have a positive result from a commercial antibody test appear to have substantial immunity to SARS-CoV-2, which means they may be at lower risk for future infection.”

  • Official UK government data show a probable reinfection rate of 0.025%, but a vaccine breakthrough rate of 23% for Delta variant infections.
  • An Irish review of 11 cohort studies involving more than 600,000 individuals who recovered from COVID found, in all studies, reinfection was “an uncommon event,” adding that there was “no study reporting an increase in the risk of reinfection over time.”
  • Israel is one of the global leaders in overall vaccination against COVID. Nevertheless, research by the Israeli Health Ministry found vaccinated individuals had 6.72 times the rate of infection as compared to those that had previously contracted COVID.
  • Another Israeli study found the naturally immune had a higher rate of protection against infection, hospitalization and severe illness as compared to those who were vaccinated.
  • In Barnstable County, Massachusetts, despite a 69% vaccination coverage rate among its eligible residents at the time of the study, the CDC found 74% of those infected in a COVID outbreak were fully vaccinated for COVID, and the vaccinated had, on average, a higher presence of the virus in their nasal cavity than the unvaccinated who were infected.
  • Following a COVID outbreak among employees of a gold mine in French Guiana, findings showed no employees with a previous history of infection were reinfected, while 63.2% of employees with no previous history of infection ended up contracting the virus.
  • Findings from researchers at the NYU School of Medicine showed “[i]n COVID patients, immune responses were characterized by a highly augmented interferon response which was largely absent in vaccine recipients.”
  • Researchers at Aarhus University Hospital in Denmark studied the immune response following COVID infections, finding the overwhelming majority of individuals who had recovered from infection had detectable, functional SARS-CoV2 spike-specific adaptive immune responses, making vaccination for any of them redundant.
  • Yale University researchers determined that “plasma from previously infected vaccinated individuals displayed overall better neutralization capacity when compared to plasma from uninfected individuals that also received two vaccine doses.”
  • University of California researchers concluded “[n]atural infection induced expansion of larger CD8 T cell clones occupied distinct clusters, likely due to the recognition of a broader set of viral epitopes presented by the virus not seen in the mRNA vaccine.”
  • study conducted by the CDC and the Wisconsin’s Department of Health Services evaluated the shedding of infectious COVID and observed high viral load in 68% of fully vaccinated individuals and in 63% of unvaccinated individuals. This demonstrates that those who are vaccinated will not only shed virus, but also will do so at the same rate as the unvaccinated. Most notably, this study did not identify anyone with prior natural infection that had any viral load.
  • Researchers at Osaka University found “the SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines.”
  • Washington University School of Medicine researchers determined “[p]eople who recover [even] from mild COVID have bone-marrow cells that can churn out antibodies for decades.”

All Of A Sudden The CDC Has Stopped Talking About Herd Immunity

Source: https://www.zerohedge.com/markets/all-sudden-cdc-has-stopped-talking-about-herd-immunity

In case you haven’t noticed, the CDC no longer looks as concerned with herd immunity as it once did. 

In what should come as no surprise to anyone watching the Covid related narrative closely (or those who have been watching the herd immunity narrative from the get-go), the CDC has “set aside herd immunity as a national goal,” according to a new report from the LA Times.

What used to be a relatively simple concept has now turned into something “very complicated”, according to Dr. Jefferson Jones, a medical officer on the CDC’s COVID-19 Epidemiology Task Force.

“Thinking that we’ll be able to achieve some kind of threshold where there’ll be no more transmission of infections may not be possible,” he said to a panel that advises the CDC last week.

While Jones says vaccines are effective against Covid, “even if vaccination were universal, the coronavirus would probably continue to spread,” the report says. 

Ergo, herd immunity seems to now be off the table. “We would discourage” thinking in terms of “a strict goal,” Jones said. 

Dr. Oliver Brooks, a member of the CDC’s Advisory Committee on Immunization Practices told the L.A. Times that “we do need to increase” the uptake of Covid shots. 

Brooks admitted that the focus moving away from herd immunity “almost makes you less motivated to get more people vaccinated.”

Kim Iversen Tackles Aaron Rodgers Controversy, Calls Out NFL on Natural Immunity, Vaccine ‘Segregation’

Source: https://childrenshealthdefense.org/defender/kim-iversen-aaron-rodgers-nfl-natural-immunity-vaccine-segregation/

On the latest episode of The Hill’s “Rising,” journalist and political commentator Kim Iversen questioned the fairness of professional sport’s COVID rules that ignore natural immunity and segregate the vaccinated — who can still get and spread COVID — from the unvaccinated.

By Jeremy Loffredo

On the latest episode of The Hill’s “Rising,” journalist and political commentator Kim Iversen broke down the National Football League’s (NFL) vaccine rules, Aaron Rodgers’ COVID controversy and the question of natural immunity in professional sports.

“Last week, Aaron Rodgers, Green Bay Packers quarterback, tested positive for COVID which has caused a firestorm of commentary from those who support him and many who don’t,” Iversen reported.

“Rodgers is doing fine and recovering as well as anyone in his age group is expected, but the controversy is surrounding Rodgers and his previous elusiveness regarding his vaccination status,” she said.

The 37-year-old reigning MVP, who told media outlets he chose not to get vaccinated because he’s allergic to an ingredient in the mRNA vaccines, has been the target of talk show hosts, including Howard Stern, Jimmy Kimmel and Jon Stewart, since confirming he was taking ivermectin and other treatments to combat the virus.

Swedish Study: Covid Jabs Provide No Lasting Protection – Immunity Plunges To ZERO In Mere Months

The Lancet – Effectiveness of Covid-19 Vaccination Against Risk of Symptomatic Infection, Hospitalization, and Death Up to 9 Months: A Swedish Total-Population Cohort Study

Source: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3949410

New research out of Sweden has found that post-vaccination “immunity” – if you can even call it that – from Wuhan coronavirus (Covid-19) injections is temporary at best, and completely gone within months.

Abstract

Background: Whether vaccine effectiveness against Coronavirus disease 2019 (Covid-19) lasts longer than 6 months is unclear.

Methods: A retrospective cohort study was conducted using Swedish nationwide registries. The cohort comprised 842,974 pairs (N=1,684,958), including individuals vaccinated with 2 doses of ChAdOx1 nCoV-19, mRNA-1273, or BNT162b2, and matched unvaccinated individuals. Cases of symptomatic infection and severe Covid-19 (hospitalization or 30-day mortality after confirmed infection) were collected from 12 January to 4 October 2021. 

Findings: Vaccine effectiveness of BNT162b2 against infection waned progressively from 92% (95% CI, 92-93, P<0·001) at day 15-30 to 47% (95% CI, 39-55, P<0·001) at day 121-180, and from day 211 and onwards no effectiveness could be detected (23%; 95% CI, -2-41, P=0·07). The effectiveness waned slightly slower for mRNA-1273, being estimated to 59% (95% CI, 18-79) from day 181 and onwards. In contrast, effectiveness of ChAdOx1 nCoV-19 was generally lower and waned faster, with no effectiveness detected from day 121 and onwards (-19%, 95% CI, -97-28), whereas effectiveness from heterologous ChAdOx1 nCoV-19 / mRNA was maintained from 121 days and onwards (66%; 95% CI, 41-80). Overall, vaccine effectiveness was lower and waned faster among men and older individuals. For the outcome severe Covid-19, effectiveness waned from 89% (95% CI, 82-93, P<0·001) at day 15-30 to 42% (95% CI, -35-75, P=0·21) from day 181 and onwards, with sensitivity analyses showing notable waning among men, older frail individuals, and individuals with comorbidities.

Interpretation: Vaccine effectiveness against symptomatic Covid-19 infection wanes progressively over time across all subgroups, but at different rate according to type of vaccine, and faster for men and older frail individuals. The effectiveness against severe illness seems to remain high through 9 months, although not for men, older frail individuals, and individuals with comorbidities. This strengthens the evidence-based rationale for administration of a third booster dose.

Lithuania, on the other hand, which currently has the world’s strictest “vaccine passport” scheme, is seeing an all-time high of new “cases” per capita within its population.

Just six weeks after the mandatory jab protocol was put into place in Lithuania, infection rates skyrocketed like never before – far outpacing that of Sweden, which is pretty much covid-free at this point (see the image below for a comparison):

swedish study covid jabs provide no lasting protection – immunity plunges to zero in mere months

BMJ Yale – Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections

Source: https://www.medrxiv.org/content/10.1101/2021.08.24.21262415v1.full.pdf

Background Reports of waning vaccine-induced immunity against COVID-19 have begun to surface. With that, the comparable long-term protection conferred by previous infection with SARS-CoV-2 remains unclear.

Methods We conducted a retrospective observational study comparing three groups: (1)SARS-CoV-2-naïve individuals who received a two-dose regimen of the BioNTech/Pfizer mRNA BNT162b2 vaccine, (2)previously infected individuals who have not been vaccinated, and (3)previously infected and single dose vaccinated individuals. Three multivariate logistic regression models were applied. In all models we evaluated four outcomes: SARS-CoV-2 infection, symptomatic disease, COVID-19-related hospitalization and death. The follow-up period of June 1 to August 14, 2021, when the Delta variant was dominant in Israel.

Results SARS-CoV-2-naïve vaccinees had a 13.06-fold (95% CI, 8.08 to 21.11) increased risk for breakthrough infection with the Delta variant compared to those previously infected, when the first event (infection or vaccination) occurred during January and February of 2021. The increased risk was significant (P<0.001) for symptomatic disease as well. When allowing the infection to occur at any time before vaccination (from March 2020 to February 2021), evidence of waning natural immunity was demonstrated, though SARS-CoV-2 naïve vaccinees had a 5.96-fold (95% CI, 4.85 to 7.33) increased risk for breakthrough infection and a 7.13-fold (95% CI, 5.51 to 9.21) increased risk for symptomatic disease. SARS-CoV-2-naïve vaccinees were also at a greater risk for COVID-19-related-hospitalizations compared to those that were previously infected.

Conclusions This study demonstrated that natural immunity confers longer lasting and stronger protection against infection, symptomatic disease and hospitalization caused by the Delta variant of SARS-CoV-2, compared to the BNT162b2 two-dose vaccine-induced immunity. Individuals who were both previously infected with SARS-CoV-2 and given a single dose of the vaccine gained additional protection against the Delta variant.